Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.
2.
3.

Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer.

Meira LB, Cheo DL, Reis AM, Claij N, Burns DK, te Riele H, Friedberg EC.

DNA Repair (Amst). 2002 Nov 3;1(11):929-34. Erratum in: DNA Repair (Amst). 2002 Dec 5;1(12):1063.

PMID:
12531020
4.

Use of nucleotide excision repair-deficient mice as a model for chemically induced lung cancer.

Cheo DL, Friedberg EC.

Methods Mol Med. 2003;74:481-91. No abstract available.

PMID:
12415716
5.

The DNA damage signal for Mdm2 regulation, Trp53 induction, and sunburn cell formation in vivo originates from actively transcribed genes.

Brash DE, Wikonkal NM, Remenyik E, van der Horst GT, Friedberg EC, Cheo DL, van Steeg H, Westerman A, van Kranen HJ.

J Invest Dermatol. 2001 Nov;117(5):1234-40.

6.

Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions.

Meira LB, Reis AM, Cheo DL, Nahari D, Burns DK, Friedberg EC.

Mutat Res. 2001 Jun 2;477(1-2):51-8. Review.

PMID:
11376686
8.

Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice.

Reis AM, Cheo DL, Meira LB, Greenblatt MS, Bond JP, Nahari D, Friedberg EC.

Cancer Res. 2000 Mar 15;60(6):1571-9.

9.

Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition.

Friedberg EC, Bond JP, Burns DK, Cheo DL, Greenblatt MS, Meira LB, Nahari D, Reis AM.

Mutat Res. 2000 Mar 20;459(2):99-108. Review.

PMID:
10725660
10.

Cancer predisposition in mutant mice defective in the XPC DNA repair gene.

Friedberg EC, Cheo DL, Meira LB, Reis AM.

Prog Exp Tumor Res. 1999;35:37-52. Review. No abstract available.

PMID:
10377750
12.

Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 2.

Friedberg EC, Meira LB, Cheo DL.

Mutat Res. 1998 Jun;407(3):217-26. No abstract available.

PMID:
9653448
13.

Genetic interaction between HAP1/REF-1 and p53.

Meira LB, Cheo DL, Hammer RE, Burns DK, Reis A, Friedberg EC.

Nat Genet. 1997 Oct;17(2):145. No abstract available.

PMID:
9326930
14.
15.

Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage.

Friedberg EC, Meira LB, Cheo DL.

Mutat Res. 1997 Mar 12;383(2):183-8. No abstract available.

PMID:
9088351
16.

Characterization of defective nucleotide excision repair in XPC mutant mice.

Cheo DL, Ruven HJ, Meira LB, Hammer RE, Burns DK, Tappe NJ, van Zeeland AA, Mullenders LH, Friedberg EC.

Mutat Res. 1997 Mar 4;374(1):1-9.

PMID:
9067411
17.
18.

Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.

Graham ML, Shuster JJ, Kamen BA, Land VJ, Borowitz MJ, Camitta B, Cheo DL, Harrison MP, Leventhal BG, Pinkel DP, Pullen DJ, Steuber P, Whitehead VM.

Clin Cancer Res. 1996 Feb;2(2):331-7.

20.

Molecular characterization of regulatory elements controlling expression of the Bacillus subtilis recA+ gene.

Cheo DL, Bayles KW, Yasbin RE.

Biochimie. 1992 Jul-Aug;74(7-8):755-62.

PMID:
1391055
21.

Inducible DNA repair and differentiation in Bacillus subtilis: interactions between global regulons.

Yasbin RE, Cheo DL, Bayles KW.

Mol Microbiol. 1992 May;6(10):1263-70. Review.

PMID:
1640829
22.

Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.

Graham ML, Shuster JJ, Kamen BA, Cheo DL, Harrison MP, Leventhal BG, Pullen DJ, Whitehead VM.

Cancer Chemother Pharmacol. 1992;31(3):217-22.

PMID:
1464159
23.
24.

Intraocular penetration of cytosine arabinoside following subconjunctival administration in primates.

Graham ML, Smiddy WE, Cheo DL, Schachat AP.

J Ocul Pharmacol. 1989 Fall;5(3):255-9.

PMID:
2625619
25.

Intraocular penetration of cytosine arabinoside following intravenous administration in primates.

Smiddy WE, Graham ML, Cheo DL, Schachat AP.

J Ocul Pharmacol. 1988 Summer;4(2):133-6.

PMID:
3171337

Supplemental Content

Support Center